ARTICLE | Financial News
Immunicon raises $24.8 million
July 10, 2003 7:00 AM UTC
Cell-based cancer diagnostic company Immunicon raised $24.8 million through the sale of convertible preferred equity. Investors included TL Ventures; Claneil Enterprises; Johnson & Johnson Development...